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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S357cartilage in inner region is not covered by the meniscus. Mechanical
loading is thought to be different in these three regions. Surgical
destabilization of the medical meniscus (DMM model) induces the
change of mechanical loading in these three regions. Understanding of
this regional change of early osteoarthritic cartilage and subchondral
bone after DMM is important to prevent progression of destructive
changes in knee joint. Our purpose was to investigate early regional
changes of cartilage and subchondral bone.
Methods: All experiments were performed according to the protocol
approved by the Animal Care and Use Committee of Our University. The
DMMmodel was created as an experimental OA model of rats, 12-week
of age. The animals were then allowed unrestricted activity, food, and
water. At the 1, 2 and 4 weeks after surgery, the rats (n ¼ 8, each
periods) were sacriﬁced and knee joints were scanned and analyzed
using Micro-CT system (SMX-100CT, Shimazu) and softwares (Amira5.4,
Visage). Then, the knee joints were ﬁxed 4% paraformaldehyde for
overnight and decalciﬁed in 10% EDTA. The samples were dehydrated
and embedded in parafﬁn. Parafﬁn sections were prepared from the
medial tibial plateau in the frontal plane and alternately stained with
Hematoxylin-Eosin (H-E) and Toluidine blue. The sections stained with
toluidine blue were evaluated with OARSI score. Immunohistochemical
staining of MMP13, Col2-3/4c, and VEGF were performed. The statistical
signiﬁcance of any difference among three regions of outer, middle and
inner in each experimental week was determined using a one-way
analysis of variance (ANOVA), followed by Tukey’s test. Descriptive
statistics were calculated as means and 95% conﬁdence interval (CI). In
all cases, P < 0.05 was considered signiﬁcant.
Results: OARSI score was increased locally in middle region with time
(middle, 1w: 5.64.2, 2w: 8.52.3, 4w: 16.11.5) and signiﬁcantly
higher compared to inner regions in 1, 2 and 4 weeks (inner, 1w:
0.00.0, 2w: 2.71.9, 4w: 3.92.0) (P < 0.05) and outer region in 4
weeks (outer, 4w: 6.61.8) (P < 0.05). Subchondral bone deﬁcits were
observed in touch with cartilage degeneration in middle region. From
histological ﬁndings, these deﬁcits were not an open communication
with the joint space that could allow ﬂuid exchange but were rather
ﬁlled with a ﬁbrous tissue. Subchondral bone fracture was conﬁrmed in
these region (Fig. 1A). The immunihistochemical localization of MMP13
and VEGF was observed in these ﬁbrous tissue (Fig. 1B, C). Although,
only mild cartilage degeneration was conﬁrmed in region of inner and
outer. Cystic mass was observed in regions of inner and outer at deep
zone of cartilage. Immuniohistochemical expression of MMP13 was
observed in these cystic mass speciﬁcally. Interestingly, immunohis-
tochemical expression of Col2-3/4c and MMP13 was observed in outer
region more than those of region of inner and middle.
Conclusions: Although, outer region expressed Col2-3/4c and MMP13
highly which indicated cartilage in this region received more chemical
stress, destructive changes of medial tibial cartilage and subchonral
bone had occurredmostly inmiddle region as primary load bearing area
which received high mechanical stress after DMM. Fibrous repair tissueFigure 1. Histological ﬁndings and Micro-CT images at the region of
subchondral bone deﬁcits. A. HE. B. VEGF positive cells (arrowheads). C.
MMP13 positive cells (arrowheads). D-F. Frontal plane of Micro-CT images
(1w, 2w, 4w). Subchondral bone deﬁcits (arrowheads). G-I. Saggital plane
of Micro-CT images (1w, 2w, 4w). Subchondral bone deﬁcits
(arrowheads).in subchonral bone might cause further cartilage degeneration due to
expression of MMP13.
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Purpose: Increasing evidence implicates the re-initiation of embryonic
processes, responsible for long bone development and growth, in
osteoarthritic pathology. We aimed to establish whether an aberrant
redeployment of the transient chondrocyte phenotype is observed in
the STR/Ort mouse (spontaneous osteoarthritis), and whether this can
be attributed to an inherent endochondral growth defect in these mice.
Furthermore, we aimed to establish the role of the Wnt inhibitor scle-
rostin and its downstream target matrix extracellular phosphoglyco-
protein (MEPE), a mineralisation inhibitor, in the maintenance of the
healthy joint, and in the regulation of these endochondral processes in
osteoarthritic joints.
Methods: STR/Ort mouse knee joints at advancing osteoarthritis stages
and age-matched CBA (control) joints were examined, by: (i) affymetrix
mouse gene microarray proﬁling of articular cartilage (AC) samples, (ii)
multiplex PCR analysis of AC and (iii) immunohistochemical labelling of
endochondral markers including sclerostin and MEPE. The endochon-
dral growth phenotype of young STR/Ort mice (1-8wks old) was ana-
lysed by standard histology, immunohistochemical labelling and by
laboratory and synchrotron x-ray computed microtomography.
Results: Our microarray studies reveal the ectopic recapitulation of
endochondral processes in AC in our STR/Ort mouse model of osteo-
arthritis evidenced, by increased expression of Col10a1 (2.31 fold),
Mmp13 (1.87 fold), Alpl (1.25 fold), Phospho1 (1.13 fold) and Enpp1
(1.59 fold) in a meta-analysis of gene array proﬁles and increased
levels of Ank (P<0.01), Phex (P<0.001), Opn (P<0.05), Dmp1
(P<0.001), Enpp1 (P<0.01) and Iﬁtm5 (P<0.01) mRNA levels by mul-
tiplex-based analysis. Our immunolabelling conﬁrms this expression
and reveals collagen type X expression in the AC of STR/Ort mice at all
ages suggesting an inherent endochondral growth defect. This was
conﬁrmed by growth plate zone analysis in which STR/Ort mice were
found to have an increased proliferative zone (PZ) of chondrocytes.
Furthermore, immunolabelling revealed collagen type X expression in
the hypertrophic zone (HZ) alone of the young CBA mice growth
plates; however, in the STR/Ort mouse, collagen type X expression was
observed in both the HZ and the PZ of chondrocytes. Immunolabelling
for MMP13 revealed a greater expression in STR/Ort mouse growth
plates in comparison to age matched CBA mice. Most interestingly,
STR/Ort mouse growth plates also show premature closure, evident
from 8 weeks of age, as shown by synchrotron radiation-based com-
puter microtomography. At 40 weeks of age growth plate closure in
the medial tibia plateau (affected) of the STR/Ort mouse is greater than
the lateral (non-affected) compartment, and both compartments in
the CBA mouse. This exciting data reveals a direct association between
the cartilage-bone transition and osteoarthritis pathology, and sug-
gests that lessons may be learnt from the molecular mechanisms
underpinning endochondral development in the pursuit of under-
standing osteoarthritis development. As such we investigated the role
of the MEPE/sclerostin axis in the development of osteoarthritis in the
STR/Ort mouse. Our immunolabelling reveals enhanced sclerostin
expression at the osteochondral interface, and enhanced MEPE
expression predominantly in the AC in the joints of CBA mice and in
unaffected regions of STR/Ort mouse joints. At advanced osteoarthritis
stages, focal suppression of sclerostin and MEPE expression is
observed in regions localised to areas of subchondral bone-thickening
and compromised AC integrity.
Conclusions: Our data reveals changes in expression patterns in
osteoarthritic mouse joints consistent with the aberrant redeployment
of endochondral processes in osteoarthritis bone pathology, attributed
to an inherent endochondral growth defect. Further investigation into
the underpinning mechanisms will identify whether targeting known
regulators of long bone development can protect against pathological
ossiﬁcation in osteoarthritis.
